drugset / Trial / NCT06834230
Effect of Dotinurad in Hyperuricemia With Hypertension
RandomizedParallel-groupOpen-labelTreatment
Summary
The effect of dotinurad on CAVI (cardio-ankle vascular index) will be compared with that of febuxostat in patients with hyperuricemia complicated by hypertension.
Timeline
- Start
- 2025-03-28
- Primary completion
- 2027-07-31
- Completion
- 2030-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dotinurad | Small molecule | 2 mg | — |
| Comparator | Febuxostat | Small molecule | 40 mg | — |